Lawrence Schachner
Dermatology · Miami, FLNPI 1063476653
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (35.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Almirall LLC at 38.9% of the total. Reporting peaked in 2019 at $177,340 and has fallen 95.2% since, to $8,468 in 2025. Among dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 185 payments — averaging $1669.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Almirall LLC$120K
- Pfizer$61K
- Regeneron Healthcare Solutions, Inc.$34K
- Dermavant Sciences, Inc.$32K
- Sanofi$17K
- Nobelpharma America, LLC$10K
- plus $36K from 19 others
Across 17 payments — averaging $9178.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$129K
- Eli Lilly$17K
- Pfizer$10K
- Bristol Myers Squibb$592
What the payments were for
- Consulting fees$92,28030%
- Speaking & faculty fees$90,29829%
- Grants$108,84035%
- Travel & lodging$7,5682%
- Food & beverage$9,7783%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Almirall LLC | 17 | $119,970 |
| Pfizer | 36 | $60,667 |
| Regeneron Healthcare Solutions, Inc. | 45 | $33,560 |
| Dermavant Sciences, Inc. | 8 | $32,086 |
| Sanofi | 8 | $17,137 |
| Nobelpharma America, LLC | 5 | $9,748 |
| Biofrontera Inc. | 7 | $7,538 |
| Novartis | 12 | $7,068 |
| Pierre Fabre Pharmaceuticals, Inc. | 4 | $5,393 |
| LNHC, Inc | 3 | $4,550 |
| Abeona Therapeutics, Inc. | 3 | $3,098 |
| Verrica Pharmaceuticals Inc. | 7 | $2,351 |
| Arcutis Biotherapeutics, Inc. | 4 | $2,176 |
| Amryt Pharma Holdings Ltd | 1 | $1,300 |
| E.r. Squibb & Sons, L.L.C. | 6 | $576 |
| Amgen | 3 | $375 |
| Incyte Corporation | 4 | $319 |
| LEO Pharma Inc. | 3 | $302 |
| AbbVie | 3 | $204 |
| Intuitive Surgical | 1 | $155 |
| Lilly USA, LLC | 1 | $125 |
| Regeneron | 1 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $7 |
| Organon | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$308,770 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.
Other dermatology in Miami
- Francisco KerdelMiami$2.1M
- Robert KirsnerMiami$1.4M
- Gil YosipovitchMiami$1M
- Mercedes GonzalezMiami$943K
- Heather Woolery LloydMiami$609K
- Hadar Lev-TovMiami$326K
- Giovanna CioccaMiami$222K
- Janice Lima MaribonaMiami$217K
- Jill WaibelMiami$116K
- Ana DuarteMiami$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.